Updated: Yesterday Location: Europe-Poland, Poland Job ID: 24002760 Description Senior Clinical Research... Associate I Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer...
: Early Careers Job Description: We are looking for an entry level Associate Credit Debt Collection with Hungarian... on the posting above, we still encourage you to reach out and apply. Research has shown that women and underrepresented...
Regulatory Intelligence Associate Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built... of regulatory source documents for the clinical regulatory intelligence. Support ad-hoc research requests from the business...
Learning & Development Associate Director, Biopharma R&D 6-Month Secondment or Fixed-term contract Location: Warsaw... across our multi-disciplinary scientific community with technical R&D subject matter experts to bring to life the end-to-end research...
), ability to manage research teams, experience of working in international teams, experience of working in foreign scientific institutions..., readiness to obtain and coordinate the implementation of research orders carried out in ACMiN laboratories. Additional...
Associate, Anti Money Laundering/Prevention/KYC Representative I Associate, Anti Money Laundering/Prevention/KYC... communication skills Attention to details, extensive research and time management skills to aid in validating required information...
Associate, Anti Money Laundering/Prevention/Know Your Client II Associate, Anti Money Laundering/Prevention/Know... and be yourself. This is what #LifeAtBNYMellon is all about. We’re seeking a future team member for the role of Associate, Anti Money Laundering/Prevention/Know...
Associate, Anti Money Laundering/Prevention/Know Your Client II Associate, Anti Money Laundering/Prevention/Know... and be yourself. This is what #LifeAtBNYMellon is all about. We’re seeking a future team member for the role of Associate, Anti Money Laundering/Prevention/Know...
Associate, Anti Money Laundering/Prevention/Know Your Client II Associate, Anti Money Laundering/Prevention/Know... and be yourself. This is what #LifeAtBNYMellon is all about. We’re seeking a future team member for the role of Associate, Anti Money Laundering/Prevention/Know...
Associate, Anti Money Laundering/Prevention/KYC Representative I Associate, Anti Money Laundering/Prevention/KYC... and be yourself. This is what #LifeAtBNYMellon is all about. We’re seeking a future team member for the role of Associate, Anti Money Laundering/Prevention/KYC...
Crude prices came under pressure after US data pointed to persistent labour market strength which further dimmed prospects of an early decline in US interest rates. Continue Reading »
Freshworks now expects annual revenue between $695 million and $705 million, compared with its previous forecast of $703.5 million to $711.5 million. Continue Reading »
While gold is traditionally considered a hedge against inflation, high interest rates kept by the US Fed to tame the rising prices can increase the opportunity cost of holding the non-yielding bullion. Continue Reading »
Manpansand Beverages' top officials have been asked to pay penalties totaling ₹74 lakh by SEBI for violations including misstating and manipulating financial statements. Continue Reading »
Stock Market Today- Cipla, Aurobindo, Torrent are 3 preferred picks of HSBC Research on healthy Q4 expectations. HSBC expects 38.4% y-o-y rise in net profit of pharma companies in their coverage during Q4 helped by rising US sales compensating for slower growth in India Continue Reading »
SK Finance's proposed IPO is a combination of a fresh issue of equity shares worth ₹500 crore and an OFS of up to ₹1,700 crore by promoters and investor shareholders Continue Reading »
Emudhra, a leading certifying authority in India, has seen its stock value surge by 245% in the past year, reaching ₹738.40. Centrum Broking in its recent note revised its price target price on the stock to ₹832 apiece. Reflecting on a strong spike in the share price, it adjusted its rating. Continue Reading »
Post FY24 results, most brokerage houses have kept their target price for Tata Chemicals at least 10% lower than the current market price Continue Reading »